CAMO-NET

Multidisciplinary global collaboration to address the impact of antimicrobial resistance.

Official CAMO-Net site

Role: Postdoctoral researcher

The Centres for Antimicrobial Optimisation Network (CAMO-Net) is a unique global research partnership which brings together institutions from Africa, Asia, Europe and South America to optimise antimicrobial use globally. With up to £11m in funding from Wellcome Trust, this ground-breaking consortium will support translational research to address major drivers of antimicrobial resistance, using a bespoke funding model to help enhance global health research equity. The consortium brings together research teams from five national hubs; the University of Liverpool (UOL) and Imperial College London (ICL) in the UK, the Amrita Institute of Medical Sciences (AIMS) and the Postgraduate Institute of Medical Education and Research (PGIMER) in India, University of Cape Town (UCT) in South Africa, the Infectious Diseases Institute in Uganda, and the Faculty of Medicine at the University of São Paulo (USP) in Brazil. These national hubs are built on existing collaborations and bring world class researchers together to address the global threat of AMR with local expertise.

The five national hubs are supported by three technical support and development centres. These quality-assured technology, research and development laboratories that support CAMO-Net activities are: the University of Ghana in Ghana, the Kamuzu University in Malawi and the Mahidol Oxford Research Unit (MORU) Tropical Health Network in Thailand.

Finally, the consortium includes three shadow national sites: the Dow University of Health Sciences in Pakistan, the Child Health Research Foundation in Bangladesh and Universidade da Paz in Timor-Leste. This shadow national sites participate in network activities to actively build research collaborations and capacity with the national hubs. Our shadow national sites are currently identifying national research priorities and will then conduct a pilot project. The goal for a future iteration of CAMO-Net is that shadow national sites would become National Hubs, and new shadow sites would be identified.

The mission of CAMO-Net is to complement and enhance the existing ecosystem of global programmes designed to alleviate the global burden and impact of antimicrobial resistance (AMR) and poorly treated infections by creating and nurturing a sustainable and equitable ecosystem for global research to optimise the use of antimicrobials in humans. This will be achieved through producing contextually relevant tools, technologies, guidelines, and practices that can be readily implemented with the support of governments and policymakers.

Events

  • 14 Dec 2023 - CAMO-Net AI meeting in London (link)
  • 21 Jun 2023 - CAMO-Net AI meeting in Liverpool (link)

Publications